Yuhua Shi1, Yuqian Cui2, Xuedong Sun3, Gang Ma4, Zengxiang Ma4, Qin Gao4, Zi-Jiang Chen5. 1. Reproductive Medicine Hospital Affiliated to Shandong University, Jinan, China. Electronic address: shiyuhua2003@126.com. 2. Renji Hospital, Shanghai Jiao Tong University School of Medicine, China. 3. Neurology Department, Provincial Hospital Affiliated to Shandong University, China. 4. Reproductive Medicine Hospital Affiliated to Shandong University, Jinan, China. 5. Reproductive Medicine Hospital Affiliated to Shandong University, Jinan, China. Electronic address: chenzijiang@hotmail.com.
Abstract
OBJECTIVE: To determine the prevalence of hypertension in women with polycystic ovary syndrome (PCOS). STUDY DESIGN: Women with PCOS (n=3396) and controls (n=1891) from a Han Chinese population were analysed retrospectively in terms of ovarian appearance on ultrasound, glucose tolerance test, hormones, lipoproteins, anthropomorphic measurements and blood pressure. RESULTS: The prevalence of hypertension was 19.2% in the women with PCOS, which was much higher than that in the controls (11.9%). After matching for body mass index, the hypertensive PCOS group had higher glucose, insulin, homeostatic model assessment (HOMA-IR) and lipid levels than the normotensive PCOS group; these differences were significant (p<0.05). CONCLUSIONS: Hypertensive PCOS patients had higher lipid, insulin and glucose levels than normotensive PCOS patients. It is likely that the incidence of long-term complications will be higher among the former group.
OBJECTIVE: To determine the prevalence of hypertension in women with polycystic ovary syndrome (PCOS). STUDY DESIGN:Women with PCOS (n=3396) and controls (n=1891) from a Han Chinese population were analysed retrospectively in terms of ovarian appearance on ultrasound, glucose tolerance test, hormones, lipoproteins, anthropomorphic measurements and blood pressure. RESULTS: The prevalence of hypertension was 19.2% in the women with PCOS, which was much higher than that in the controls (11.9%). After matching for body mass index, the hypertensive PCOS group had higher glucose, insulin, homeostatic model assessment (HOMA-IR) and lipid levels than the normotensive PCOS group; these differences were significant (p<0.05). CONCLUSIONS:Hypertensive PCOSpatients had higher lipid, insulin and glucose levels than normotensive PCOSpatients. It is likely that the incidence of long-term complications will be higher among the former group.
Authors: Roberto Mioni; Anna Dalla Cà; Jenni Turra; Sara Azzolini; Nadia Xamin; Luigi Bleve; Pietro Maffei; Roberto Vettor; Francesco Fallo Journal: Endocrine Date: 2016-05-03 Impact factor: 3.633
Authors: Victor B Ribeiro; Gislaine S Kogure; Rosana M Reis; Ada C Gastaldi; João E DE Araújo; José H Mazon; Audrey Borghi; Hugo C D Souza Journal: Int J Exerc Sci Date: 2016-11-01
Authors: Sergio Davinelli; Daria Nicolosi; Cinzia Di Cesare; Giovanni Scapagnini; Roberto Di Marco Journal: J Clin Med Date: 2020-04-02 Impact factor: 4.241
Authors: Edgar D Torres Fernandez; Kristen V Adams; Maryam Syed; Rodrigo O Maranon; Damian G Romero; Licy L Yanes Cardozo Journal: J Endocr Soc Date: 2018-07-10